We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHRT
2276
AH Realty Trust
AHRT
$517M
| $516K | ﹤0.01% |
49,599
-29,751
| -37% | -$337K |
|
2277
Enpro
NPO
$7.05B
| $516K | ﹤0.01% |
3,056
| – | – |
|
|
ENFN
2278
DELISTED
Enfusion, Inc.
ENFN
| $514K | ﹤0.01% |
55,595
+23,606
| +74% | +$208K |
|
2279
RE/MAX Holdings
RMAX
$242M
| $514K | ﹤0.01% |
58,584
+47,898
| +448% | +$462K |
|
2280
Mitek Systems
MITK
$834M
| $514K | ﹤0.01% |
36,432
-99,252
| -73% | -$1.22M |
|
|
BCPC
2281
Balchem Corp
BCPC
$5.72B
| $513K | ﹤0.01% |
3,312
+645
| +24% | +$95.6K |
|
|
ZIMV
2282
DELISTED
ZimVie
ZIMV
| $513K | ﹤0.01% |
31,105
-78,965
| -72% | -$1.41M |
|
|
SPNS
2283
DELISTED
Sapiens International
SPNS
| $511K | ﹤0.01% |
15,898
-18,311
| -54% | -$531K |
|
2284
Genesco
GCO
$422M
| $511K | ﹤0.01% |
+18,164
| New | +$524K |
|
2285
NeoGenomics
NEO
$2.13B
| $511K | ﹤0.01% |
32,500
-12,400
| -28% | -$191K |
|
2286
Core Laboratories
CLB
$521M
| $509K | ﹤0.01% |
29,800
-32,660
| -52% | -$514K |
|
2287
First Commonwealth Financial
FCF
$2.17B
| $509K | ﹤0.01% |
+36,531
| New | +$504K |
|
|
SACH
2288
Sachem Capital Corp
SACH
$39.8M
| $507K | ﹤0.01% |
113,621
-149,526
| -57% | -$575K |
|
2289
Spyre Therapeutics
SYRE
$9.25B
| $507K | ﹤0.01% |
13,355
-14,740
| -52% | -$427K |
|
2290
HBT Financial
HBT
$1.32B
| $505K | ﹤0.01% |
26,519
+590
| +2% | +$11.5K |
|
2291
Autohome
ATHM
$2.62B
| $503K | ﹤0.01% |
19,200
-4,700
| -20% | -$122K |
|
2292
NextDecade
NEXT
$1.78B
| $503K | ﹤0.01% |
88,598
-18,380
| -17% | -$91.8K |
|
2293
NACCO Industries
NC
$320M
| $500K | ﹤0.01% |
16,547
+4,500
| +37% | +$152K |
|
2294
Strategic Education
STRA
$1.92B
| $499K | ﹤0.01% |
+4,796
| New | +$469K |
|
2295
Biomea Fusion
BMEA
$91.3M
| $499K | ﹤0.01% |
33,401
-104,837
| -76% | -$1.73M |
|
2296
ProShares Russell 2000 Dividend Growers ETF
SMDV
$710M
| $499K | ﹤0.01% |
+7,800
| New | +$485K |
|
2297
Lennar Class A
LEN
$21.2B
| $499K | ﹤0.01% |
2,997
| – | – |
|
|
HEPS
2298
D-Market Electronic Services & Trading
HEPS
$990M
| $496K | ﹤0.01% |
330,494
-115,702
| -26% | -$183K |
|
2299
Valens Semiconductor
VLN
$188M
| $494K | ﹤0.01% |
210,268
-20,064
| -9% | -$45.5K |
|
2300
Smartbird Inc
BIRD
$22.3M
| $494K | ﹤0.01% |
35,593
-18,430
| -34% | -$344K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.